These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23250311)

  • 1. [Epidemiological surveillance of measles and Germán measles (rubella) within the context of the elimination plan: Colombia, 1995-2009].
    Morón-Duarte LS; Castillo-Pabón JO
    Rev Salud Publica (Bogota); 2012; 14(1):1-14. PubMed ID: 23250311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
    Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
    Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian vaccine preventable disease epidemiological review series: rubella 2008-2012.
    Chan J; Dey A; Wang H; Martin N; Beard F
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E19-26. PubMed ID: 26063094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verifying the Elimination of Measles and Rubella in the WHO European region: the Case of Spain.
    Santos Preciado JI
    Rev Esp Salud Publica; 2015; 89(4):353-5. PubMed ID: 26580790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating measles and rubella surveillance: the experience in the Caribbean.
    Irons B; Carrasco P; Morris-Glasgow V; Castillo-Solórzano C; de Quadros CA
    J Infect Dis; 2003 May; 187 Suppl 1():S153-7. PubMed ID: 12721907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The seroprevalence of IgG antibodies against rubella (German measles) in 10-49 year-old women from Cartagena, Colombia].
    Mora-García GJ; Ramos-Clason E; Mazenett E; Gómez-Camargo D
    Rev Salud Publica (Bogota); 2011 Apr; 13(2):288-97. PubMed ID: 22030886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age Group-Based Monitoring of the Progress in Measles and Rubella Elimination: Search for a Population Size/Density-Independent Parameter.
    Yoshikura H
    Jpn J Infect Dis; 2015; 68(6):533-5. PubMed ID: 26370432
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced measles surveillance during an interepidemic period in Victoria.
    Lambert SB; Kelly HA; Andrews RM; Catton MC; Lynch PA; Leydon JA; Gercovich DK; Hogg GG; Morgan ML; Lester RA
    Med J Aust; 2000 Feb; 172(3):114-8. PubMed ID: 10735021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plan for the Elimination of Measles and Rubella in Spain].
    Limia Sánchez A
    Rev Esp Salud Publica; 2015; 89(4):393-6. PubMed ID: 26580794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seroprevalence in Niger from 2005 to 2019: estimates from the epidemiological surveillance of measles].
    Sante Publique; 2021 Nov; Vol. 33(4):591-596. PubMed ID: 35485115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiologic surveillance of measles and rubella in Campinas (SP), Brazil: the reliability of the data].
    de Barros EN; Silva EM
    Rev Panam Salud Publica; 2006 Mar; 19(3):172-8. PubMed ID: 16640846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination.
    Winter AK; Martinez ME; Cutts FT; Moss WJ; Ferrari MJ; McKee A; Lessler J; Hayford K; Wallinga J; Metcalf CJE
    J Infect Dis; 2018 Jul; 218(3):355-364. PubMed ID: 29562334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The elimination of measles and rubella in Italy].
    Adamo G; Sturabotti G; De Soccio P; Prencipe GP; Sciarra I; Baccolini V; Massimi A; Marzuillo C; Iannazzo S; Villari P
    Ig Sanita Pubbl; 2017; 73(5):429-442. PubMed ID: 29433130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft.
    Matter HC; Cloetta J; Zimmermann H
    J Epidemiol Community Health; 1995 Aug; 49 Suppl 1(Suppl 1):4-8. PubMed ID: 7561669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of rubella in 2010-2012 in Kinshasa, Democratic Republic of Congo: data from the measles case-based surveillance system].
    Nsambu MN; Coulibaly T; Donnen P; Dramaix-Wilmet M; Likwela JL
    Sante Publique; 2014; 26(3):393-7. PubMed ID: 25291888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles and rubella eradication in Alaska.
    Eisenberg M; Crowe JD
    JAMA; 1976 Jan; 235(2):179-80. PubMed ID: 946025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008-2009.
    García-Comas L; Sanz Moreno JC; Ordobás Gavín M; Barranco Ordóñez D; García Gutiérrez J; Ramos Blázquez B; Rodero Garduño I
    J Infect Public Health; 2015; 8(5):432-40. PubMed ID: 25957894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.